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Background: Data on miscarriage in pregnant women with COVID-19 are still 
limited, as well as the mechanism that causes miscarriage in women with 
COVID-19. This study aims to report the mechanism of miscarriage that occurs 
in patients with COVID-19 from various literature. 
Case presentation: We reported a case of miscarriage occurred in a woman 
aged 28 years, 11-week pregnancy with COVID-19 in Batin Mangunang Re-
gional General Hospital, Lampung Province, Indonesia. 
Conclusion: Pregnant women infected with COVID-19 are at risk for miscar-
riage. 
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The number of COVID-19 cases globally has reached 
170,051,718 cases, with a death toll of 3,540,437 patients 
and 2% befallen in pregnant women. The prevalence of 
COVID-19 in Indonesia has reached 1,809,926 confirmed 
cases, with many mortality reaching 50,262 patients. How-
ever, data on the loss of pregnant women with COVID-19 
have not been reported.1,2  
 
To this point, research and data discoursing miscarriage 
in patients with confirmed COVID-19 remain limited. 
Research confirms that the occurrence of miscarriage 
associated with SARS-CoV, MARS-CoV, and SARS-CoV-
2 is 14.5%.2 Nonetheless, the mechanism of miscarriage 
in COVID-19 patients has not been widely discussed. This 
study reports the incidence of miscarriage in pregnant 
women with COVID-19 and describes the mechanisms of 
miscarriage related to COVID-19 from various literature. 
CASE PRESENTATION 
A 28-year-old mother in 11 weeks of pregnancy visited the 
Emergency Unit of the Hospital with complaints of lower 
abdominal pain accompanied by vaginal bleeding. The 
provisional examination result was that the patient had a 
miscarriage. Based on anamnesis results, the patient said 
that he did not have risk factors for miscarriage, such as a 
history of falls, anemia, and other chronic diseases. How-
ever, the patient experienced diarrhea for one week, ac-
companied by heartburn. The patient's general condition 
was weak with a dry cough slightly, blood pressure 120/80 
mmHg, pulse 86x / minute, respiration 20x / minute, and a 
36.8 °C.  
 
Patients were screened for COVID-19 using a rapid anti-
body test with reactive IgM and IgG results. Then it was 
confirmed by PCR examination with positive results. The 
doctor diagnosed the patient with an incomplete abortion 
and was infected with COVID-19. The patient was sub-
jected to curettage and then treated in an isolation room. 
Antibiotic therapy, Nonsteroidal anti-inflammatory drugs 
(NSAIDs), antihemorrhagic agents were administered to 
prevent infection and further blood loss. The patient was 
also given a multivitamin to increase immunity. 
DISCUSSION  
Pregnant women are a group at risk of contracting infec-
tions, one of which is a respiratory infection. Due to physi-
ological changes in pregnancy, it results in a decline in the 
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immune system so that pregnant women are more sus-
ceptible to infectious diseases, including the COVID-19 in-
fection, which is currently widespread.3–6 The patient indi-
cated a rapid test for IgM antibody, reactive IgG, and pos-
itive PCR, which meant that the patient had been exposed 
to COVID-19 on 2 to 3 weeks before the miscarriage oc-
curred. 
 
Symptoms of COVID-19 infection include fever, cough, di-
arrhea, fatigue.2,4 In this case, the patient also experienced 
diarrhea for one week and fatigue. Diarrhea can cause de-
hydration which may lead to the volume of the amnion be-
ing reduced, resulting in disruption of fetal development or 
even miscarriage. In addition, physical fatigue triggers 
uterine contractions that result in miscarriage. Miscarriage 
can also occur due to intra-abdominal pressure caused by 
intense and repeated coughing. 
 
Another possibility of miscarriage in a mother infected with 
COVID-19 occurs due to placental insufficiency, which in-
hibits nutrition and oxygen so that the fetus experiences 
hypoxia, and miscarriage occurred.7–9 The decrease in the 
kisspeptin hormone may cause the placenta not to implant 
properly on the uterine wall resulting in miscarriage.10–12 
 
The risk of proinflammatory cytokine storm increases in 
pregnant women infected with COVID-19. This cytokine 
storm can cause severe inflammation that causes damage 
to various organs, one of which is the placenta, so that 
miscarriage can occur.13–15 
CONCLUSIONS AND RECOMMENDATION 
Miscarriages that occur in pregnant women with COVID-
19 may occur due to symptoms caused by infections such 
as coughing, diarrhea, and fatigue, in addition to hormonal 
influences and damage to the placenta. Further research 
is required regarding the exact causes and mechanisms of 
miscarriage in pregnant women with COVID-19. 
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